Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasms.

Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasms.

The vast majority of gastrin-related gastrointestinal neuroendocrine neoplasms (GI-NENs) develop in the context of chronic atrophic gastritis (type 1), a condition closely related to autoimmune thyroid diseases. These neoplasms are defined as gastric NENs type 1 (GNEN1) and have recently been shown...

Full description

Bibliographic Details
Main Authors:	Kaltsas, G, Grozinsky-Glasberg, S, Alexandraki, K, Thomas, D, Tsolakis, A, Gross, D, Grossman, AB
Format:	Journal article
Language:	English
Published:	Blackwell Publishing Ltd 2014

Similar Items

The role of somatostatin analogues in the treatment of neuroendocrine tumours.
by: Grozinsky-Glasberg, S, et al.
Published: (2008)

Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms.
by: Grozinsky-Glasberg, S, et al.
Published: (2008)

Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
by: Inbal Uri, et al.
Published: (2018-07-01)

Preclinical drug studies in MEN1-related neuroendocrine neoplasms (MEN1-NENs)
by: Grozinsky-Glasberg, S, et al.
Published: (2020)

Current Status and Controversies in the Diagnosis and Treatment of Gastric Neuroendocrine Neoplasms
by: CUI Ting, et al.
Published: (2023-03-01)

Gastric mixed neuroendocrine non-neuroendocrine neoplasms
by: Li Liu, et al.
Published: (2024-04-01)

Preliminary report of the use of everolimus in a patient with progressive medullary thyroid carcinoma
by: Druce, M, et al.
Published: (2012)

Preliminary report of the use of everolimus in a patient with progressive medullary thyroid carcinoma.
by: Druce, M, et al.
Published: (2012)

The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours.
by: Kaltsas, G, et al.
Published: (2001)

Are serotonin metabolite levels related to bone mineral density in patients with neuroendocrine tumours?
by: Gupta, P, et al.
Published: (2014)

Are serotonin metabolite levels related to bone mineral density in patients with neuroendocrine tumours?
by: Sen Gupta, P, et al.
Published: (2014)

The diagnosis and medical management of advanced neuroendocrine tumors.
by: Kaltsas, G, et al.
Published: (2004)

Clinical and pathologic characteristics of appendiceal neuroendocrine neoplasms diagnosed during pregnancy
by: Orit Twito, et al.
Published: (2023-02-01)

Morphological classification of digestive neuroendocrine neoplasms: the current concepts and controversies
by: V. V. Delektorskaya
Published: (2016-09-01)

Gastric neuroendocrine neoplasm with late liver metastasis
by: Bernardo Marques, et al.
Published: (2018-08-01)

Prognosis of Poorly-differentiated Gastric Neuroendocrine Neoplasm
by: ZHANG Jian, et al.
Published: (2019-05-01)

Evaluation of the Association between Serotonin and Bone Mineral Density in Patients with Neuroendocrine Tumors
by: Den Gupta, P, et al.
Published: (2011)

The Global mTOR Inhibitor Torin1 Is More Effective than the mTORC1 Inhibitor, Everolimus, Alone or in Combination with Histone Deacetylase Inhibitors, in Suppressing Neuroendocrine Tumor Cell Proliferation
by: Grozinsky-Glasberg, S, et al.
Published: (2011)

Long-term surgical outcomes of gastric neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasms
by: Kenichi Iwasaki, et al.
Published: (2022-05-01)

Mixed Neuroendocrine Non-Neuroendocrine Neoplasm Arising in the Ectopic Gastric Mucosa of Esophagus
by: Ryosuke Gushima, et al.
Published: (2022-12-01)

Type 3 gastric neuroendocrine neoplasms: the rising promise of conservative endoscopic management
by: Elisabetta Dell’Unto, et al.
Published: (2024-01-01)

Neuroendocrine immune responses to inflammation: the concept of the neuroendocrine immune loop.
by: Chikanza, I, et al.
Published: (1996)

Therapeutic Challenges for Gastric Neuroendocrine Neoplasms: Take It or Leave It?
by: Federica Cavalcoli, et al.
Published: (2023-10-01)

Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues.
by: Kaltsas, G, et al.
Published: (2005)

A Case of Gastric Mixed Neuroendocrine-Nonneuroendocrine Neoplasm Composed With Adenoma and Neuroendocrine Tumor
by: Kwon-Eui Hong, et al.
Published: (2023-12-01)

Gastric Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: A Western Center Case Series
by: Marcus Fernando Kodama Pertille Ramos, et al.
Published: (2021-06-01)

Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms
by: Melpomeni Fani, et al.
Published: (2017-03-01)

Clinicopathological characteristics of gastric neuroendocrine neoplasms: A comprehensive analysis
by: Mengli Zi, et al.
Published: (2024-02-01)

Paraneoplastic syndromes secondary to neuroendocrine tumours.
by: Kaltsas, G, et al.
Published: (2010)

Preliminary Report of the Use of Everolimus in a Patient with Progressive Medullary Thyroid Carcinoma
by: Druce, M, et al.
Published: (2010)

The role of chemotherapy in the nonsurgical management of malignant neuroendocrine tumours.
by: Kaltsas, G, et al.
Published: (2001)

Circulating miRNA-202-3p is a potential novel biomarker for diagnosis of type 1 gastric neuroendocrine neoplasms
by: Dou Dou, et al.
Published: (2021-04-01)

Novel insights in the diagnosis of Cushing's syndrome.
by: Alexandraki, K, et al.
Published: (2010)

Endocrinology in the time of COVID-19: Clinical management of neuroendocrine neoplasms (NENs)
by: Casey, RT, et al.
Published: (2020)

Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours.
by: Kaltsas, G, et al.
Published: (2004)

Models in Pancreatic Neuroendocrine Neoplasms: Current Perspectives and Future Directions
by: Steven D. Forsythe, et al.
Published: (2023-07-01)

Epigenetic pathway inhibitors represent potential drugs for treating pancreatic and bronchial neuroendocrine tumors
by: Lines, K, et al.
Published: (2017)

Is urinary free cortisol of value in the diagnosis of Cushing's syndrome?
by: Alexandraki, K, et al.
Published: (2011)

Management of Appendix Neuroendocrine Neoplasms: Insights on the Current Guidelines
by: Amr Mohamed, et al.
Published: (2022-12-01)

The role of chemotherapy management of malignant in the nonsurgical neuroendocrine tumours
by: Kaltsas, G, et al.
Published: (2001)